344 related articles for article (PubMed ID: 9746793)
1. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.
Shear HL; Grinberg L; Gilman J; Fabry ME; Stamatoyannopoulos G; Goldberg DE; Nagel RL
Blood; 1998 Oct; 92(7):2520-6. PubMed ID: 9746793
[TBL] [Abstract][Full Text] [Related]
2. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
3. Malaria in beta-thalassemic mice and the effects of the transgenic human beta-globin gene and splenectomy.
Roth EF; Shear HL; Costantini F; Tanowitz HB; Nagel RL
J Lab Clin Med; 1988 Jan; 111(1):35-41. PubMed ID: 3335824
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
5. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.
Shear HL; Marino MW; Wanidworanun C; Berman JW; Nagel RL
Am J Trop Med Hyg; 1998 Dec; 59(6):852-8. PubMed ID: 9886187
[TBL] [Abstract][Full Text] [Related]
6. Comparative histopathology of mice infected with the 17XL and 17XNL strains of Plasmodium yoelii.
Fu Y; Ding Y; Zhou TL; Ou QY; Xu WY
J Parasitol; 2012 Apr; 98(2):310-5. PubMed ID: 22017443
[TBL] [Abstract][Full Text] [Related]
7. Protection from lethal malaria in transgenic mice expressing sickle hemoglobin.
Hood AT; Fabry ME; Costantini F; Nagel RL; Shear HL
Blood; 1996 Feb; 87(4):1600-3. PubMed ID: 8608253
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria.
Shear HL; Roth EF; Fabry ME; Costantini FD; Pachnis A; Hood A; Nagel RL
Blood; 1993 Jan; 81(1):222-6. PubMed ID: 8417791
[TBL] [Abstract][Full Text] [Related]
9. Duffy antigen is important for the lethal effect of the lethal strain of Plasmodium yoelii 17XL.
Akimitsu N; Kim HS; Hamamoto H; Kamura K; Fukuma N; Arimitsu N; Ono K; Wataya Y; Torii M; Sekimizu K
Parasitol Res; 2004 Aug; 93(6):499-503. PubMed ID: 15278442
[TBL] [Abstract][Full Text] [Related]
10. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
11. Critical role of Erythrocyte Binding-Like protein of the rodent malaria parasite Plasmodium yoelii to establish an irreversible connection with the erythrocyte during invasion.
Kegawa Y; Asada M; Ishizaki T; Yahata K; Kaneko O
Parasitol Int; 2018 Dec; 67(6):706-714. PubMed ID: 30025976
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
Kobayashi F; Ishida H; Matsui T; Tsuji M
J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium yoelii blood-stage primes macrophage-mediated innate immune response through modulation of toll-like receptor signalling.
Fu Y; Ding Y; Zhou T; Fu X; Xu W
Malar J; 2012 Apr; 11():104. PubMed ID: 22463100
[TBL] [Abstract][Full Text] [Related]
15. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
Front Immunol; 2019; 10():2207. PubMed ID: 31608052
[TBL] [Abstract][Full Text] [Related]
16. Expression of non-TLR pattern recognition receptors in the spleen of BALB/c mice infected with Plasmodium yoelii and Plasmodium chabaudi chabaudi AS.
Rosanas-Urgell A; Martin-Jaular L; Ricarte-Filho J; Ferrer M; Kalko S; Kimura E; Del Portillo HA
Mem Inst Oswaldo Cruz; 2012 May; 107(3):410-5. PubMed ID: 22510838
[TBL] [Abstract][Full Text] [Related]
17. Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors.
Mutungi JK; Yahata K; Sakaguchi M; Kaneko O
Mol Biochem Parasitol; 2015 Nov; 204(1):26-33. PubMed ID: 26684675
[TBL] [Abstract][Full Text] [Related]
18. Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection.
Taylor KJ; Van TT; MacDonald SM; Meshnick SR; Fernley RT; Macreadie IG; Smooker PM
Parasite Immunol; 2015 Jan; 37(1):23-31. PubMed ID: 25376500
[TBL] [Abstract][Full Text] [Related]
19. Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.
Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
Malar J; 2011 Apr; 10():103. PubMed ID: 21518429
[TBL] [Abstract][Full Text] [Related]
20. Immunity to erythrocytic stages of malarial parasites.
Long CA; Daly TM; Kima P; Srivastava I
Am J Trop Med Hyg; 1994; 50(4 Suppl):27-32. PubMed ID: 7909653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
